Drug
Gabapentin B Complex
Gabapentin B Complex: highest development phase Post-Market, developed by Merck. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Gabapentin/B-complex NCT01364298 | Post-Market | Diabetic Peripheral Neuropathic Pain |
Latest
No recent events.
Follow Gabapentin B Complex on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.